» Articles » PMID: 21257960

Limiting the Amount and Duration of Antigen Exposure During Priming Increases Memory T Cell Requirement for Costimulation During Recall

Overview
Journal J Immunol
Date 2011 Jan 25
PMID 21257960
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Donor-reactive memory T cells (Tmem) can play an important role in mediating graft rejection after transplantation. Transplant recipients acquire donor-reactive Tmem not only through prior sensitization with alloantigens but also through previous exposure to environmental pathogens that are cross-reactive with allogeneic peptide-MHC complexes. Current dogma suggests that most, if not all, Tmem responses are independent of the requirement for CD28 and/or CD154/CD40-mediated costimulation to mount a recall response. However, heterogeneity among Tmem is increasingly being appreciated, and one important factor known to impact the function and phenotype of Ag-specific T cell responses is the amount/duration of Ag exposure. Importantly, the impact of Ag exposure on development of costimulation independence is currently unknown. In this study, we interrogated the effect of decreased Ag amount/duration during priming on the ability of donor-reactive Tmem to mediate costimulation blockade-resistant rejection during a recall response after transplantation in a murine model. Recipients possessing donor-reactive Tmem responses that were generated under conditions of reduced Ag exposure exhibited similar frequencies of Ag-specific T cells at day 30 postinfection, but, strikingly, failed to mediate costimulation blockade-resistant rejection after challenge with an OVA-expressing skin graft. Thus, these data demonstrate the amount/duration of Ag exposure is a critical factor in determining Tmem's relative requirement for costimulation during the recall response after transplantation.

Citing Articles

Activation and regulation of alloreactive T cell immunity in solid organ transplantation.

Duneton C, Winterberg P, Ford M Nat Rev Nephrol. 2022; 18(10):663-676.

PMID: 35902775 PMC: 9968399. DOI: 10.1038/s41581-022-00600-0.


CD122 signaling in CD8+ memory T cells drives costimulation-independent rejection.

Mathews D, Dong Y, Higginbotham L, Kim S, Breeden C, Stobert E J Clin Invest. 2018; 128(10):4557-4572.

PMID: 30222140 PMC: 6159972. DOI: 10.1172/JCI95914.


2B4 Mediates Inhibition of CD8 T Cell Responses via Attenuation of Glycolysis and Cell Division.

Laurie S, Liu D, Wagener M, Stark P, Terhorst C, Ford M J Immunol. 2018; 201(5):1536-1548.

PMID: 30012849 PMC: 6103805. DOI: 10.4049/jimmunol.1701240.


Transplantation preferentially induces a KLRG-1 CD127 differentiation program in antigen-specific CD8 T cells.

Bozeman A, Laurie S, Divya Haridas , Wagener M, Ford M Transpl Immunol. 2018; 50:34-42.

PMID: 29885905 PMC: 6188810. DOI: 10.1016/j.trim.2018.06.003.


Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.

Liu D, Badell I, Ford M JCI Insight. 2018; 3(1).

PMID: 29321374 PMC: 5821191. DOI: 10.1172/jci.insight.96378.


References
1.
Valujskikh A, Pantenburg B, Heeger P . Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant. 2002; 2(6):501-9. DOI: 10.1034/j.1600-6143.2002.20603.x. View

2.
Adams A, Williams M, Jones T, Shirasugi N, Durham M, Kaech S . Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest. 2003; 111(12):1887-95. PMC: 161424. DOI: 10.1172/JCI17477. View

3.
Bingaman A, Farber D . Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant. 2004; 4(6):846-52. DOI: 10.1111/j.1600-6143.2004.00453.x. View

4.
Welsh R, Markees T, Woda B, Daniels K, Brehm M, Mordes J . Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol. 2000; 74(5):2210-8. PMC: 111702. DOI: 10.1128/jvi.74.5.2210-2218.2000. View

5.
Bluestone J, St Clair E, Turka L . CTLA4Ig: bridging the basic immunology with clinical application. Immunity. 2006; 24(3):233-8. DOI: 10.1016/j.immuni.2006.03.001. View